Health and healthcare are certain to be radically transformed through the application of discoveries in genetics and genomic medicine.
We aim to harness advances in genetics, genome biology and genome technologies to improve the understanding and management of common and rare diseases, as well as cancer. This will be achieved through cutting-edge research, integration with medical care, and education and training.
The Imperial College AHSC partner organisations along with Chelsea and Westminster Hospital NHS Foundation Trust were designated one of the first 11 Genomic Medicine Centres (GMCs) by NHS England in 2014. As the West London GMC, they will contribute to the successful delivery of the 100,000 Genomes Project. This is a national initiative that aims to sequence 100,000 genomes from around 70,000 participants, for the first time, to enable new scientific discoveries and medical insights, and bring benefits to patients. The trusts will collaborate to gather samples and medical information of participants with cancer or inherited rare diseases.
To complement the GMC initiative, Imperial College has launched a new MSc in Genomic Medicine. The course is aimed at students from a wide range of backgrounds, from core discipline scientists to all levels of healthcare professionals, and provides a flexible, multi-disciplinary and multi-professional perspective in genomics, applied to clinical practice and medical research.